Y. Shirasaki, Molecular design for enhancement of ocular penetration, J Pharm Sci, vol.97, issue.7, pp.2462-96, 2008.

I. P. Kaur and M. Kanwar, Ocular preparations: the formulation approach, Drug Dev Ind Pharm, vol.28, issue.5, pp.473-93, 2002.

G. Torkildsen and T. P. O'brien, Conjunctival tissue pharmacokinetic properties of topical azithromycin 1 % and moxifloxacin 0.5 % ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers, Clin Ther, vol.30, pp.2005-2019, 2008.

K. Schmitz, P. Banditt, and M. Motschmann, Population pharmacokinetics of 2 % topical dorzolamide in the aqueous humor of humans, Invest Ophthalmol Vis Sci, vol.40, pp.1621-1625, 1999.

D. Amo, E. M. Urtti, and A. , Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data, Exp Eye Res, vol.137, pp.111-135, 2015.

S. Sharma, S. Mulik, and N. Kumar, An anti-inflammatory role of VEGFR2/Src kinase inhibitor in HSV-1 induced immunopathology, J Virol, vol.85, issue.12, pp.5995-6007, 2011.

N. Worakul and J. R. Robinson, Ocular pharmacokinetics/pharmacodynamics, Eur J Pharm Biopharm, vol.44, pp.71-83, 1997.

V. P. Ranta and A. Urtti, Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling, Adv Drug Deliv Rev, vol.58, pp.1164-81, 2006.

P. M. Hughes, O. Olejnik, and J. E. Chang-lin, Topical and systemic drug delivery to the posterior segments, Adv Drug Deliv Rev, vol.57, pp.2010-2042, 2005.

M. O. Karlsson and R. M. Savic, Diagnosing model diagnostics, Clin Pharmacol Ther, vol.82, issue.1, pp.17-20, 2007.

M. Bergstrand, A. C. Hooker, and J. E. Wallin, Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models, AAPS J, vol.13, issue.2, pp.143-51, 2011.

C. R. Pamulapati and R. D. Schoenwald, Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: compartmental analysis and PK-PD evaluation, J Pharm Sci, vol.101, issue.1, pp.414-437, 2012.

K. Sakanaka, K. Kawazu, and M. Tomonari, Ocular pharmacokinetic/pharmacodynamic modeling for bunazosin after instillation into rabbits, Pharm Res, vol.21, issue.5, pp.770-776, 2004.

K. Sakanaka, K. Kawazu, and M. Tomonari, Ocular pharmacokinetic/pharmacodynamic modeling for multiple anti-glaucoma drugs, Biol Pharm Bull, vol.31, issue.8, pp.1590-1595, 2008.

K. Abduljalil, M. Diestelhorst, and O. Doroshyenko, Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops, Eur J Clin Pharmacol, vol.64, issue.5, pp.521-530, 2008.

R. Gaudana, H. K. Ananthula, and A. Parenky, Ocular drug delivery, AAPS J, vol.12, issue.3, pp.348-60, 2010.

U. B. Kompella, R. S. Kadam, and V. H. Lee, Recent advances in ophthalmic drug delivery, Ther Deliv, vol.1, issue.3, pp.435-56, 2010.